Basic information
Biomarker: HE4
Histology type: endometrial carcinoma
Stage: low-grade
Cohort characteristics
Country: Australia
Region: Victoria
Study type: single-site prospective study
Followed up time :
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
100 | endometrial cancer or CAH. | 100 |
Sample information
Conclusion: When used in conjunction with an initial low-grade endometrial biopsy, serum HE4 level demonstrated a similar likelihood to both preoperative MRI and intraoperative frozen section in identifying low-risk disease on final histopathology.
Sample type : serum
Sample method: ARCHITECT HE4 assay
Expression pattern : <70 pmol/L
Disease information
Statictics: Mean (SD);Range
Cohort age: 64.6;36–88
Related information
Funtion Uniprot: Broad range protease inhibitor.
UniProt ID: Q14508
UniProt Link: https://www.uniprot.org/uniprotkb/Q14508/entry
Molecular function from UniProt:
Tissue specificity from UniProt: Expressed in a number of normal tissues, including male reproductive system, regions of the respiratory tract and nasopharynx. Highly expressed in a number of tumors cells lines, such ovarian, colon, breast, lung and renal cells lines. Initially described as being exclusively transcribed in the epididymis.
Subcellular UniProt: #Secreted
Alternative name from UniProt:
Recommended name: WAP four-disulfide core domain protein 2
Gene name from HGNC: WFDC2 (dJ461P17.6, EDDM4, HE4, WAP5)
HPA class: Cancer-related genes
AlphaFold DB: Q14508
AlphaFold Link: https://alphafold.ebi.ac.uk/entry/Q14508
HPA link: https://www.proteinatlas.org/ENSG00000101443-WFDC2
Tissue specificity RNA from HPA: Tissue enhanced (cervix, salivary gland)
Tissue expression from HPA: Cytoplasmic expression in selected tissues.
Single cell type specificity Cell type enhanced (Club cells, Glandular and luminal cells, Basal respiratory cells, Urothelial cells, Endometrial ciliated cells, Respiratory ciliated cells, Collecting duct cells)
Immune cell specificity: Not detected in immune cells
Subcellular summary HPA Secreted
Cancer prognostic summary HPA Prognostic marker in glioma (unfavorable) and renal cancer (favorable)
Pathology link: https://www.proteinatlas.org/ENSG00000101443-WFDC2/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000101443-WFDC2/pathology/pathology/endometrial+cancer
OMIM: 617548
OMIM link2: https://www.omim.org/entry/617548
HGNC ID: HGNC:15939
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:15939